Operations · The model
How a Peptide Business Actually Works
The storefront is the part everyone sees. The real business is the infrastructure underneath it. Here is how the pieces fit together.
Before we start. This article is provided for general educational purposes and is not legal, regulatory, medical or financial advice. The requirements applicable to a business depend on its products, activities, jurisdictions and operating model. Retabionix figures reflect our own historical business performance and are not typical or guaranteed results.
Spend enough time researching how to start a peptide business and you may come away thinking the model is simple: find a supplier, create a brand, build a website and start acquiring customers.
At the highest level, that isn’t wrong. It is incomplete in the way that saying a restaurant “buys ingredients and sells meals” is correct. It skips almost everything that decides whether the business works.
We know because we had to build those systems ourselves. Our own peptide brand, Retabionix, today generates approximately $500,000 per month across B2B and B2C revenue. Getting there changed how we understand this industry.
Our biggest lesson was that the website selling peptides was only the front of what we were building. Behind it sat an operating system connecting supply, products, testing and documentation, inventory, payments, fulfillment, customer acquisition, compliance considerations and, eventually, multiple routes to market.
If you’re considering this industry, understanding that before you start may save you a great deal of time.
There Isn’t Really One “Peptide Business”
This is the first thing we’d clarify with someone who tells us they want to enter the industry.
“What business are you actually trying to build?”
Online, the term “peptide business” is used as if it describes one model. A research-focused ecommerce company, a B2B supplier and a healthcare or telehealth business involving licensed providers and pharmacies can all sit within the broader peptide economy while operating under very different commercial and regulatory frameworks.
Why the model decides the requirements
That distinction matters more now that regulatory scrutiny has increased.
Human drug compounding is one example. Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act create distinct pathways with specific conditions. FDA also maintains categories of bulk substances nominated for compounding and currently identifies a number of peptide substances as presenting potential significant safety risks or insufficient safety information. The agency’s current list discusses substances including BPC-157, CJC-1295, GHK-Cu for injectable use, ipamorelin, MOTs-C and others.
We take a broader principle from it.
Your business model determines the infrastructure and requirements you need. The product alone doesn’t determine the business.
So we’d decide what we’re building before choosing a logo, website or catalog.
The Business Customers See and the Business They Don’t
A customer sees something simple. They find a brand, browse products, read a product page and check out, and a package arrives. That’s the experience you’re trying to create.
Behind it may sit your corporate structure, product strategy, suppliers, testing and documentation, inventory, packaging, ecommerce stack, payment infrastructure, fulfillment, customer service, analytics, professional advisors, marketing systems and operational procedures.
We’ve found it useful to think of the business as an iceberg.
The brand, website and products are visible. Most of what makes the company function is not.
That creates an early trap for new founders. You spend your time on the things you can see.
Choosing a name, seeing the first packaging render and watching a homepage come together are all satisfying.
It’s less exciting to map what happens when a supplier has a delay, a payment provider requests information, an order is shipped incorrectly or inventory for your fastest-moving SKU starts running low.
Those systems may end up mattering more than the shade of blue on your homepage.
A good-looking storefront on weak infrastructure is still a weak business.
Start by Following Two Things
If we were examining a new peptide business today, we’d map two journeys before going into the details.
Journey one
Follow the product
- Where does it originate?
- What happens between the original source and your company?
- What documentation exists?
- What testing is appropriate for the particular product and model?
- Where is inventory held?
- How is it packaged?
- Who fulfills the order?
- What happens when stock runs low?
- What happens when something goes wrong?
Journey two
Follow the dollar
- Where does the customer come from?
- What does acquiring them cost?
- What do they purchase?
- Who processes the transaction?
- What fees and costs are incurred?
- When is the money available to the company?
- What does fulfillment cost?
- What gets refunded?
- What remains after all variable costs?
Those two maps show a lot. A business can look healthy from outside while one of the paths has a problem in it. Good infrastructure makes both journeys predictable.
Finding a Supplier Is Only the Beginning
One of the most common questions in this industry is:
“Where can I find a peptide supplier?”
It’s a fair question, asked at the wrong level. Someone willing to sell you product is not a dependable supply chain. Once you operate commercially, you think about consistency, documentation, lead times, batch management, minimum quantities, inventory planning, packaging, logistics, testing and contingency.
What a test result does and doesn’t tell you
Depending on the model, the requirements can get very specific. FDA’s treatment of peptide substances in the human-compounding context shows why operators need to look beyond a generic “purity” number. The agency discusses potential issues such as aggregation, peptide-related impurities, immunogenicity and API characterization for various peptide substances.
We keep one distinction in mind.
A test result answers the question that test was designed to answer. It does not answer every question about a product.
A headline purity percentage can reassure buyers, but it shouldn’t replace knowing what was tested, which method was used, and what the result does and does not show.
Here, experienced technical and regulatory advice matters. The right quality framework depends on what you sell and how you sell it. The business lesson is simpler.
Design the supply chain first. Then source product into it.
Treat Your Product Catalog as a Portfolio
Another early temptation is to launch with as many products as possible. A big catalog can make a company look established, but every extra SKU may add inventory, forecasting, packaging, working capital and operational complexity.
Suppose you launch 30 products because you want an impressive catalog.
Much of that catalog may be capital sitting on shelves.
What job does each product do?
Real transaction data changes how you see products. One SKU may be good at acquiring new customers. Another may account for an outsized share of average order value. Some products may often be bought together. Another may interest a B2B customer far more than an individual consumer.
That changes the question from:
“What products can we sell?”
to:
“What job does each product perform within this business?”
A strong catalog is one where the products make sense together, commercially and operationally, whatever its size.
The Two-Second Checkout Has an Entire Financial System Behind It
A customer enters card details, clicks a button and sees a confirmation screen two seconds later. For the business, a lot happens in those two seconds.
Behind it are payment processors, acquiring relationships, fraud controls, chargebacks, settlement periods, reserves, underwriting, provider policies and category-specific risk decisions.
One of the biggest mistakes a founder can make is treating payment processing as a website feature instead of business infrastructure. A processor that is easy to connect does not necessarily support every business model or product category. Provider policies matter. So does describing your business accurately, and so does the risk of depending heavily on one outside provider.
Know where your critical dependencies are
We use a simple test.
If one outside company changing its mind could stop your business operating tomorrow, treat that company as a critical dependency.
- Payments
- Fulfillment
- Supply
The right response is to understand the category you operate in, work with appropriate providers, comply with their requirements and know where your critical dependencies are. Disguising what the business is, or trying to get around provider policies, is not the answer.
The same principle applies well beyond peptides.
Fulfillment Looks Boring Until You Start Growing
Early-stage businesses can hide bad systems well. At 20 orders per month, the founder can catch a wrong address, update an order by hand, answer every support email and check inventory personally. The business seems to work because human effort fills the gaps.
Growth changes the arithmetic. Imagine a fulfillment process with a 1% error rate.
The same 1% error rate, at two different volumes
At 20 orders / month
0.2
affected orders. You may go months without noticing a problem.
At 5,000 orders / month
50
problem orders. Nothing became proportionally worse.
The weakness was already there. Volume made it visible.
This was one of our more important operating lessons.
Scale reveals the operational weaknesses that were already there.
The same arithmetic applies to refunds, chargebacks, failed payments, support requests, shipping errors, inventory discrepancies and nearly every other percentage in an ecommerce business. At enough volume, decimals become departments.
So we’d rather find weaknesses before sending real demand into a business than celebrate the demand and deal with the consequences later.
Marketing Is Fuel for the Machine
Customer acquisition is the part many entrepreneurs find exciting. It’s also where we see the order of work get reversed.
Imagine we could send a new peptide company 1,000 customers tomorrow. That is good news only if the company is ready for them.
If inventory can’t support demand, fulfillment can’t process the volume, support becomes overwhelmed, payment infrastructure encounters problems or the unit economics don’t work, successful marketing has only brought the underlying problem forward.
One of our operating principles covers this.
Build the machine before you pour fuel on it.
The machine is the product, infrastructure and operations.
You don’t need a large corporate operation before your first sale. Early businesses should test, learn and improve. But customer acquisition shouldn’t run as a separate activity, cut off from everything that happens after the customer clicks.
- Traffic matters only when it turns into orders.
- Orders matter only when the business can fill them well and at a profit.
- The target is economically valuable demand that the business can serve again and again.
That is a higher bar than traffic or order count.
Marketing in This Industry Has Another Layer
Marketing a health-adjacent product category also takes more discipline than marketing phone cases.
The FTC’s health-products guidance says advertising must be truthful and non-misleading and that objective claims need appropriate substantiation. Regulators look beyond the literal words in an advertisement. The FTC considers both express and implied claims and looks at the overall “net impression” created by text, imagery, product names and other elements.
For marketers, this matters. Avoiding one phrase may not avoid an unsupported health claim if the advertisement as a whole communicates the same message.
What counts as advertising
“Advertising” here goes well beyond paid media. FTC guidance covers websites, digital content, social media, influencers, packaging, promotional materials and other communications designed to increase demand.
We take a business principle from the legal language.
The more regulated or scrutinized the category, the earlier marketing and compliance need to speak to each other.
Compliance shouldn’t be the person who sees finished copy five minutes before an ad goes live. It should shape what the company says, how it positions products and what evidence it needs to support objective claims in the first place.
Copying competitors isn’t due diligence either. A competitor running an ad shows that they ran it. It says nothing about whether the ad is compliant.
The Business Changes Again When B2B Enters the Picture
At Retabionix, our approximately $500,000 in monthly revenue today comes from a mix of B2C and B2B sales. The two run as separate commercial engines, each with its own levers.
Engine one
B2C
Here you work the standard consumer ecommerce levers.
- Customer acquisition cost
- Conversion rate
- Average order value
- Repeat purchasing
- Retention
- Customer experience
- Brand
Engine two
B2B
B2B runs on a different set of dynamics.
- Individual relationships can represent considerably larger order values
- Sales cycles and purchasing behavior differ
- Reliability becomes especially important
- Account management matters
- Forecasting changes when one customer equals many consumers
What we learned was that the first obvious way to make money may not be the whole business.
A founder may enter an industry seeing one customer and later find several types of customer served by the same infrastructure. That’s worth considering before you design the whole company around one channel.
Revenue Is Only the Surface-Level Metric
Revenue screenshots dominate entrepreneurial marketing because revenue is easy to understand. A business did $100,000, and everyone gets the number.
Running the business makes you ask harder questions.
- How much did it cost to generate that revenue?
- What were gross margins?
- How much working capital did growth consume?
- How much came from existing customers?
- What did fulfillment cost?
- How concentrated was revenue among products or customers?
- What was refunded?
- What was the payment failure rate?
- How much inventory is sitting idle?
- How much cash is available?
Revenue tells you that transactions happened. It doesn’t tell you whether you should want more of the same transactions.
That’s why we increasingly think in terms of systems and unit economics rather than screenshots. A company doing $300,000 with healthy economics, repeat customers and dependable infrastructure can be a stronger business than one doing $1 million with broken margins, enormous customer-acquisition costs and constant operational problems.
Top-line revenue gets attention. What sits underneath it decides the quality of the business.
Eventually, You Realize You’re Building a Loop
Once the pieces start working together, the business stops looking like a linear checklist.
Each stage changes the next, and the last one changes the first.
Product strategy influences supply. Supply influences inventory. Inventory affects what can be marketed. Marketing creates demand. Demand creates transaction data. Transaction data tells you which products and customer segments matter. That information changes purchasing and inventory decisions. Customer behavior influences the next marketing decision. B2B demand can change forecasting again. Then the cycle repeats.
Over time, the company learns from its own results.
At this point data becomes one of the most valuable things the business produces. You can start replacing assumptions with evidence about which products sell, what customers buy together, where they came from, which channels produce repeat customers, where margin comes from and which parts of the operation are creating friction.
A mature business works as a feedback system rather than a set of separate departments. The better information moves through it, the better decisions can be.
Why We Understand This Differently Now
The order matters here. We built a peptide company first, and PeptiCEOs came later.
That company is Retabionix. It generated approximately $500,000 in its first 45 days and today generates around $500,000 per month across B2B and B2C revenue. Those are our own results, not a forecast or representation of what another business should expect to achieve.
For this article, what matters is what happened behind the number. Running the company forced us to solve problems in supply, products, payments, fulfillment, customer acquisition, operations and multiple routes to market. Some problems were obvious before we started. Others only showed up once enough transactions were going through the machine.
By then we had also built a blueprint alongside Retabionix.
It is not a formula, a guarantee of revenue or a shortcut around the responsibilities that come with owning a business.
It is a blueprint in the literal sense. It gives a clearer picture of what has to exist, which pieces depend on each other, what order things should happen in, which relationships matter and where new founders are most likely to underestimate the difficulty.
That experience became the foundation for PeptiCEOs. We cover how it played out in more detail in the Retabionix case study.
The Question We’d Ask Differently Today
Most people researching this opportunity begin with some variation of:
“How do I start a peptide website?”
Having operated one, we’d ask:
“How do I build a peptide business?”
The first question sends you toward Shopify themes, logos, product pages and suppliers. The second makes you think about the commercial model, products, supply chain, quality, documentation, payments, fulfillment, operations, customer acquisition, unit economics, compliance, risk and growth.
Once those pieces are thought through, the website is the straightforward part.
The website is where the customer experiences the business. The business is everything behind it.
You Don’t Need to Become an Expert in Every Piece
You don’t need to master everything covered here before you start.
That’s why we created Pepti Blueprint.
We don’t hand you a video library, point you toward a few vendors and leave you to assemble the company yourself. Our team builds the business for you, using the infrastructure, relationships and operating experience we’ve developed from working in this industry.
Frequently Asked Questions
What does a peptide business actually consist of?
Far more than a storefront. The visible layer is the brand, website and products. Underneath sit corporate structure, product strategy, suppliers, testing and documentation, inventory, packaging, the ecommerce stack, payment infrastructure, fulfillment, customer service, analytics, professional advisors, marketing systems and operational procedures. The website is where the customer experiences the business; it is not the business itself.
Is there only one type of peptide business?
No, and this is the first thing worth clarifying. A research-focused ecommerce company, a B2B supplier, and a healthcare or telehealth business involving licensed providers and pharmacies can all sit within the broader peptide economy while operating under very different commercial and regulatory frameworks. Your business model determines the infrastructure and requirements you need. The product alone does not.
How many products should a new peptide brand launch with?
Fewer than most founders expect. Every additional SKU adds inventory, forecasting, packaging, working capital and operational complexity. Launch 30 products and you may find six account for most sales, twelve move occasionally, and twelve barely move at all, which is capital sitting on shelves rather than more opportunity. The better question is what job each product performs within the business.
Why do small operational error rates matter as a business grows?
Because volume makes them visible. A 1% fulfillment error rate at 20 orders a month is 0.2 affected orders, which you may never notice. The same 1% at 5,000 orders a month is 50 problem orders. Nothing became proportionally worse; the weakness was already there. The same arithmetic applies to refunds, chargebacks, failed payments, support requests and inventory discrepancies.
What does the FTC expect from health-product advertising?
Its health-products guidance says advertising must be truthful and non-misleading, and that objective claims need appropriate substantiation. Regulators look at express and implied claims and at the overall net impression created by text, imagery, product names and other elements, so avoiding one phrase does not help if the ad as a whole communicates the same message. The guidance also extends beyond paid media to websites, social content, influencers, packaging and promotional materials.
Sources referenced FDA, Compounding Laws and Policies · FDA, Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks · FTC, Health Products Compliance Guidance
This article is provided for general educational purposes and is not legal, regulatory, medical or financial advice. The requirements applicable to a business depend on its products, activities, jurisdictions and operating model. Retabionix figures reflect our own historical business performance and are not typical or guaranteed results.
Next step
Thinking About Building Your Own Peptide Brand?
If you’re seriously considering the market, we’re happy to look at what you want to build. On a Pepti Blueprint Strategy Call, we review your goals, experience, resources and the type of company you want to create. We walk through the major pieces involved, what your path could look like, and whether it makes sense for us to build it with you.
If there’s a fit, we’ll show you how Pepti Blueprint works and what we’d build for you. If there isn’t, we’ll tell you that too. You can also read the whole build, step by step, before you speak to anyone.
We accept three partners per month. Applications are reviewed in the order they arrive.